Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
OwnerHaixiang Lin, Lie Liinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides a polynucleotide adjuvant composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine). The present invention further contemplates methods of use of such adjuvant compositions, particularly in eliciting an immune response, in particular a mucosal immune response to an antigenic compound.
Claims12
An immunogenic composition comprising PIKA and an antigen, wherein the composition is formulated for mucosal administration.
Dependencies are inferred from the claim text.